Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ · Healthcare
Whitehawk Therapeutics, Inc. Net Income 2018–2025
Whitehawk Therapeutics, Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Whitehawk Therapeutics, Inc. net income for the quarter ending March 31, 2026 was -22.2 M, a 130.40% decrease year-over-year.
- Whitehawk Therapeutics, Inc. net income for the twelve months ending March 31, 2026 was -19.5 M, a 68.34% decrease year-over-year.
- Whitehawk Therapeutics, Inc. annual net income for 2025 was -20.6 M, a 67.66% decrease from 2024.
- Whitehawk Therapeutics, Inc. annual net income for 2024 was -63.7 M, a 3.15% decrease from 2023.
- Whitehawk Therapeutics, Inc. annual net income for 2023 was -65.8 M, a 8.68% increase from 2022.
- Whitehawk Therapeutics, Inc. annual net income for 2022 was -60.5 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Whitehawk Therapeutics, Inc. Net Income — FAQ
Whitehawk Therapeutics, Inc. (WHWK) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Whitehawk Therapeutics, Inc.'s net income?
Whitehawk Therapeutics, Inc. (WHWK) reported net income of -$21M for fiscal 2025.
Where can I see WHWK's net income history?
The chart and table above show Whitehawk Therapeutics, Inc.'s net income by year and by quarter, including the growth rate.